Fulcrum Therapeutics
FULC
FULC
126 hedge funds and large institutions have $570M invested in Fulcrum Therapeutics in 2024 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
+25
Holders Change %
+24.75%
% of All Funds
1.83%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
36
Increased
33
Reduced
29
Closed
11
Calls
$30.4M
Puts
$1.21M
Net Calls
+$29.2M
Net Calls Change
+$25.4M
Top Buyers
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$10.7M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$4.53M |
| 3 |
Millennium Management
New York
|
+$4.34M |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$4.02M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$3.76M |
Top Sellers
| 1 |
SCM
Suvretta Capital Management
New York
|
-$25.2M |
| 2 |
Morgan Stanley
New York
|
-$12.1M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
-$8.1M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.81M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.78M |
